Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis

Cell Metabolism

Volumn 21, Issue 5, 2015, Pages 739-746

  Koliaki, Chrysi ^a,b   Szendroedi, Julia ^a,b   Kaul, Kirti ^a,b   Jelenik, Tomas ^a,b   Nowotny, Peter ^a,b   Jankowiak, Frank ^a   Herder, Christian ^a,b   Carstensen, Maren ^a,b   Krausch, Markus ^a   Knoefel, Wolfram Trudo ^a   Schlensak, Matthias ^c   Roden, Michael ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c St Martinus Krankenhaus Dusseldorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADIPONECTIN; FIBROBLAST GROWTH FACTOR 21; HYDROGEN PEROXIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LIPID PEROXIDE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BREATHING; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER BIOPSY; LIVER FUNCTION; LIVER MITOCHONDRION; MALE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIROMETRY; CELL RESPIRATION; COMPLICATION; FATTY LIVER; LIPID PEROXIDATION; LIVER; METABOLISM; PATHOLOGY;

ADULT; CELL RESPIRATION; FATTY LIVER; FEMALE; HUMANS; HYDROGEN PEROXIDE; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS;

EID: 84937738375     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.04.004     Document Type: Article

References (34)

1. Benard, G., Faustin, B., Passerieux, E., Galinier, A., Rocher, C., Bellance, N., Delage, J.P., Casteilla, L., Letellier, T., Rossignol, R., Physiological diversity of mitochondrial oxidative phosphorylation. Am. J. Physiol. Cell Physiol. 291 (2006), C1172–C1182.
2. Buchner, D.A., Yazbek, S.N., Solinas, P., Burrage, L.C., Morgan, M.G., Hoppel, C.L., Nadeau, J.H., Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance. Obesity (Silver Spring) 19 (2011), 917–924.
3. Chavez, A.O., Molina-Carrion, M., Abdul-Ghani, M.A., Folli, F., Defronzo, R.A., Tripathy, D., Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 32 (2009), 1542–1546.
4. Chavin, K.D., Yang, S., Lin, H.Z., Chatham, J., Chacko, V.P., Hoek, J.B., Walajtys-Rode, E., Rashid, A., Chen, C.H., Huang, C.C., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274 (1999), 5692–5700.
5. Chiappini, F., Barrier, A., Saffroy, R., Domart, M.C., Dagues, N., Azoulay, D., Sebagh, M., Franc, B., Chevalier, S., Debuire, B., et al. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Invest. 86 (2006), 154–165.
6. Cusi, K., Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology, 142, 2012, 711.e6.
7. Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.D., Iwakura, Y., Hersberger, M., Kopf, M., Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 14 (2013), 1045–1053.
8. Frezza, C., Cipolat, S., Scorrano, L., Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2 (2007), 287–295.
9. Gornicka, A., Morris-Stiff, G., Thapaliya, S., Papouchado, B.G., Berk, M., Feldstein, A.E., Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis. Antioxid. Redox Signal. 15 (2011), 437–445.
10. Jelenik, T., Séquaris, G., Kaul, K., Ouwens, D.M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A.L., Janke, L., et al. Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes. Diabetes 63 (2014), 3856–3867.
11. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., et al., Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
12. Koliaki, C., Roden, M., Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol. Cell. Endocrinol. 379 (2013), 35–42.
13. Kuznetsov, A.V., Strobl, D., Ruttmann, E., Königsrainer, A., Margreiter, R., Gnaiger, E., Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal. Biochem. 305 (2002), 186–194.
14. Mantena, S.K., Vaughn, D.P., Andringa, K.K., Eccleston, H.B., King, A.L., Abrams, G.A., Doeller, J.E., Kraus, D.W., Darley-Usmar, V.M., Bailey, S.M., High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem. J. 417 (2009), 183–193.
15. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003), 267–273.
16. Morino, K., Petersen, K.F., Dufour, S., Befroy, D., Frattini, J., Shatzkes, N., Neschen, S., White, M.F., Bilz, S., Sono, S., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115 (2005), 3587–3593.
17. Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
18. Nair, S., P Chacko, V., Arnold, C., Diehl, A.M., Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am. J. Gastroenterol. 98 (2003), 466–470.
19. Pérez-Carreras, M., Del Hoyo, P., Martín, M.A., Rubio, J.C., Martín, A., Castellano, G., Colina, F., Arenas, J., Solis-Herruzo, J.A., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (2003), 999–1007.
20. Pessayre, D., Role of mitochondria in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 22:1 (2007), S20–S27.
21. Roden, M., Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance. Nat. Clin. Pract. Endocrinol. Metab. 2 (2006), 335–348.
22. Sanyal, A.J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W.B., Contos, M.J., Sterling, R.K., Luketic, V.A., Shiffman, M.L., Clore, J.N., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001), 1183–1192.
23. Satapati, S., Sunny, N.E., Kucejova, B., Fu, X., He, T.T., Méndez-Lucas, A., Shelton, J.M., Perales, J.C., Browning, J.D., Burgess, S.C., Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 53 (2012), 1080–1092.
24. Schmid, A.I., Szendroedi, J., Chmelik, M., Krssák, M., Moser, E., Roden, M., Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34 (2011), 448–453.
25. Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., Wakasa, K., In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37 (2002), 56–62.
26. Serviddio, G., Bellanti, F., Tamborra, R., Rollo, T., Capitanio, N., Romano, A.D., Sastre, J., Vendemiale, G., Altomare, E., Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 57 (2008), 957–965.
27. Singh, R., Wang, Y., Xiang, Y., Tanaka, K.E., Gaarde, W.A., Czaja, M.J., Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49 (2009), 87–96.
28. Starkov, A.A., Measurement of mitochondrial ROS production. Methods Mol. Biol. 648 (2010), 245–255.
29. Sunny, N.E., Parks, E.J., Browning, J.D., Burgess, S.C., Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14 (2011), 804–810.
30. Suomalainen, A., Elo, J.M., Pietiläinen, K.H., Hakonen, A.H., Sevastianova, K., Korpela, M., Isohanni, P., Marjavaara, S.K., Tyni, T., Kiuru-Enari, S., et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10 (2011), 806–818.
31. Szendroedi, J., Schmid, A.I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., Roden, M., Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med., 4, 2007, e154.
32. Szendroedi, J., Chmelik, M., Schmid, A.I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., Roden, M., Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50 (2009), 1079–1086.
33. Wang, L., Liu, X., Nie, J., Zhang, J., Kimball, S.R., Zhang, H., Zhang, W.J., Jefferson, L.S., Cheng, Z., Ji, Q., Shi, Y., ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology 61 (2015), 486–496.
34. Wikstrom, J.D., Sereda, S.B., Stiles, L., Elorza, A., Allister, E.M., Neilson, A., Ferrick, D.A., Wheeler, M.B., Shirihai, O.S., A novel high-throughput assay for islet respiration reveals uncoupling of rodent and human islets. PLoS ONE, 7, 2012, e33023.